Presentation
A conference organized by European Medicines Agency (EMA) and Medicines and Medical Devices Agency of Serbia (ALIMS) entitled: “Reinforcing Communication to Patients and Healthcare Professionals” was held in Belgrade, on 23rd June 2014 as part of the project in the scope of Instrument for Pre-accession Assistance (IPA) of the European Union
9.40 P.ZELIC Introduction to ALIMS
10.00 G.DANIELSSON Oversight of Clinical Trials in Europe Member State perspective
10.20 T.SPATHOPOULOU Oversight of Clinical Trials in the EU EMA-perspective
10.40 N.DEDES Norms related to Ethical CT A Patients Perspective
11.30 A.SEGEC Pharmacovigilance in the European Union
12.15 J.RAINE The role of PRAC in Pharmacovigilance Decisions
12.25 J.RAINE Pharmacovigilance requirements for Member States
12.35 J.GARCIA J.RAINE Safety communication and its role in risk minimisation
14-30 I.MOULON Cooperation between EMA and patients and healthcare professionals organisations
14.45 D.HAERRY Overview of EMAs interaction with patients and consumers organisations 2013
15.30 F.HOUYEZ Supply shortages of medicines in Europe
16.20 I.VANEVSKI ALIMS Web portal
16.50 J.GARCIA Communication to patients consumers and healthcare professionals